NO942680L - Fremgangsmåte for å lage universelle donorceller - Google Patents

Fremgangsmåte for å lage universelle donorceller

Info

Publication number
NO942680L
NO942680L NO942680A NO942680A NO942680L NO 942680 L NO942680 L NO 942680L NO 942680 A NO942680 A NO 942680A NO 942680 A NO942680 A NO 942680A NO 942680 L NO942680 L NO 942680L
Authority
NO
Norway
Prior art keywords
procedure
donor cells
universal donor
making universal
making
Prior art date
Application number
NO942680A
Other languages
English (en)
Norwegian (no)
Other versions
NO942680D0 (no
Inventor
Tania L Weiss
Marvin R Garovoy
Anthony Hunt
Bing Huey
Schuman Tam
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO942680D0 publication Critical patent/NO942680D0/no
Publication of NO942680L publication Critical patent/NO942680L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/353—Nature of the modification linked to the nucleic acid via an atom other than carbon
    • C12N2310/3535—Nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
NO942680A 1992-01-31 1994-07-15 Fremgangsmåte for å lage universelle donorceller NO942680L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83042792A 1992-01-31 1992-01-31
US94486892A 1992-09-14 1992-09-14
PCT/US1993/000797 WO1993014769A1 (fr) 1992-01-31 1993-01-29 Procede de production de cellules donneuses universelles

Publications (2)

Publication Number Publication Date
NO942680D0 NO942680D0 (no) 1994-07-15
NO942680L true NO942680L (no) 1994-08-24

Family

ID=27125355

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942680A NO942680L (no) 1992-01-31 1994-07-15 Fremgangsmåte for å lage universelle donorceller

Country Status (9)

Country Link
EP (1) EP0626852A4 (fr)
JP (1) JPH07503612A (fr)
AU (1) AU3598293A (fr)
BR (1) BR9307844A (fr)
CA (1) CA2126692A1 (fr)
CZ (1) CZ178394A3 (fr)
HU (1) HUT67676A (fr)
NO (1) NO942680L (fr)
WO (1) WO1993014769A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110946A1 (fr) 1992-12-09 1994-06-10 Elazar Rabbani Methode pour rendre un element du corps immunocompatible au moyen d'un construit d'acide nucleique, construit d'acide nucleique servant a inhiber ou a reguler la fonction d'un gene de la reponse immunitaire et element immunocompatible contenant un construit d'acide nucleique servant a inhiber ou a reguler la fonction d'un gene de la reponse
CA2158933A1 (fr) * 1993-09-03 1995-03-09 John F. Warner Methodes de suppression du rejet de greffes
DE69426303T2 (de) * 1993-09-03 2001-05-31 Chiron Corp Verfahren zur unterdrückung der immunantwort durch gentherapie
JPH09503655A (ja) * 1993-09-03 1997-04-15 チロン ビアジーン インコーポレイティド 自己免疫応答の抑制方法
DE10019252A1 (de) * 2000-04-18 2001-10-31 Klaus Karl Degitz Polydesoxyribonukleotide zur Hemmung der ICAM-1-Genexpression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2732544B2 (ja) * 1990-08-14 1998-03-30 アイシス・ファーマシューティカルス・インコーポレーテッド 細胞接着のオリゴヌクレオチド変調
DE69332668T2 (de) * 1992-09-02 2003-12-18 Isis Pharmaceutical Inc Beeinflussing der zelladhäsie durch oligonukleotide
CA2110946A1 (fr) * 1992-12-09 1994-06-10 Elazar Rabbani Methode pour rendre un element du corps immunocompatible au moyen d'un construit d'acide nucleique, construit d'acide nucleique servant a inhiber ou a reguler la fonction d'un gene de la reponse immunitaire et element immunocompatible contenant un construit d'acide nucleique servant a inhiber ou a reguler la fonction d'un gene de la reponse

Also Published As

Publication number Publication date
WO1993014769A1 (fr) 1993-08-05
EP0626852A1 (fr) 1994-12-07
CZ178394A3 (en) 1995-03-15
HU9402188D0 (en) 1994-09-28
EP0626852A4 (en) 1996-03-20
CA2126692A1 (fr) 1993-08-05
BR9307844A (pt) 1996-01-09
HUT67676A (en) 1995-04-28
AU3598293A (en) 1993-09-01
NO942680D0 (no) 1994-07-15
JPH07503612A (ja) 1995-04-20

Similar Documents

Publication Publication Date Title
DK0506945T3 (da) Fremgangsmåde til genoverførsel under anvendelse af retrotransposoner
AU6548096A (en) Solution containing chaotropic agent and process using it for isolation of dna, rna and proteins
AR013400A1 (es) Aislado de moleculas de adn, constructos que lo incluyen, vectores, celulas huespedes que incluyen dicho constructo, plantas transgenicas que incluyendichas celulas y metodo para identificar regiones de enlace utilizando dichos aislados.
DK0752869T3 (da) Celler med talrige ændrede epitoper på et overfladeantigen til anvendelse ved transplantationen
KR900004937A (ko) 특이한 rna 배열 순서를 분할하는 rna 촉매
ATE132902T1 (de) Humane mangan-superoxiddismutase (hmn-sod)
NO962950L (no) Fremgangsmåte for fremstilling av adeno-assosierte viruser (AAV), og deres anvendelse
DK338788A (da) Fremgangsmaade til transformering af celler
SE8800157D0 (sv) Transformation and foreign gene expression in brassica species
IL132580A0 (en) Genetically engineered duckweed
NO942680L (no) Fremgangsmåte for å lage universelle donorceller
EP0249432A3 (fr) Transformation et expression de gènes étrangers avec des espèces végétales
ES2096484T3 (es) Bloques constitutivos con enlaces de carbamato entre nucleosidos y nuevos oligonucleotidos derivados de los mismos.
DE60213852D1 (de) Herstellung von zellsuspensionen
NZ307444A (en) Polyphenol oxidase genes from lettuce and banana
UA70915C2 (uk) Спосіб індукування стійкості до вірусу, що містить послідовність потрійного блока генів 3, за умови, що це не х вірус картоплі, у клітині рослини або рослині, трансгенна рослина, стійка до вірусу
WO1997005276A3 (fr) Procede de sequençage par hydridation d'oligomeres
WO2004007694A3 (fr) Systeme hautement efficace de transformation de ligne germinale
ES2100173T3 (es) Procedimiento para la integracion de adn dirigida al sitio en el genoma de plantas.
EP0207165A4 (fr) Vecteur de secretion de polypeptides, micro-organismes transformes par ledit vecteur, et procede de preparation de polypeptides avec lesdits micro-organismes.
WO2020176412A3 (fr) Compositions et procédés pour entraîner une diversité d'événements t1
BR0015368A (pt) Molécula/sequência de dna, proteìna e sequência polinucleotìdea isoladas, vetor, células de plantas transformada, planta transgênica e método de modulação de divisão celular de planta e de isolamento de um gene revoluta
DE69737597D1 (de) Vektoren zur inhibierung von viralem und tumorwachstum
Pucheu et al. Immunological Studies on the Cross-Binding and Cross-Reconstitution of Maize and Spinach Coupling Factors CF1
Melanie Creating the right balance